UCLA Cardiovascular Center — Los Angeles, California

UCLA Cardiovascular Center is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Cardiovascular Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Urothelial Carcinoma, Cardiomyopathy, Atrial Fibrillation.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, University of Rochester, Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Cardiovascular Center?

UCLA Cardiovascular Center has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Cardiovascular Center conducted?

UCLA Cardiovascular Center has 4 clinical trials on record, with 2 currently active. Their work covers Urothelial Carcinoma, Cardiomyopathy, Atrial Fibrillation.

Is UCLA Cardiovascular Center accredited by Crixeo Health?

UCLA Cardiovascular Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Cardiovascular Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.